Gilead Sciences, Inc. (Nasdaq: GILD) announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) f...
Clinicians benefit from a more robust and streamlined documentation experience on Cerner Building upon the introduction of bi-directional ambient sync for...
-Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases, announced a new organi...
United Digestive now offers patients receiving a colonoscopy an enhanced screening by GI Genius™ intelligent endoscopy module. The GI Geniu...
New research looking at the mental health and eating behaviours of patients 1-year after bariatric surgery has found that a short, 7-session telephone cogn...
Etiometry, the leader in clinical decision-support software, announced today its IVCO2 Index™was cleared by the Food and Drug Administration for use ...
Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organ...
Grifols will apply artificial intelligence technologies, including large language models, to speed up the development of new biopharma therapeutics Agre...
Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic K...
Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as ...
Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...
Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...
Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...
Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned init...
© 2024 Biopharma Boardroom. All Rights Reserved.
